<?xml version="1.0" encoding="UTF-8"?>
<fn-group>
 <fn id="d33e343">
  <p id="ntpara0015">
   <bold>Grant Support:</bold> Supported in part by grants 
   <funding-source id="gs2">CA</funding-source> 107476 and 
   <funding-source id="gs3">CA</funding-source> 168762 (SVR) from the 
   <funding-source id="gs4">
    <institution-wrap>
     <institution-id institution-id-type="doi">10.13039/100000054</institution-id>
     <institution>National Cancer Institute</institution>
    </institution-wrap>
   </funding-source>, Rockville, MD; and 1R01DA044284-01A1 (EKC) from the National Institute on Drug Abuse, Bethesda, MD.
  </p>
 </fn>
 <fn id="d33e356">
  <p id="ntpara0010">
   <bold>Potential Competing Interests:</bold> The authors report no competing interests.
  </p>
 </fn>
</fn-group>
